PillPack’s Recent Public Battles Amazon’s PillPack is fighting battles everyday, as it tries to wrest revenue, profit, and valuation from deeply entrenched players in this (mostly) zero-sum game. However, as with everything else: you win some and you lose some. Below...
High-Reimbursement Drugs – Why? High reimbursement drug products have been an underground current in the practice of pharmacy for over a decade. However, only in the past 5 or 10 years has this part of the industry expanded enough to bring federal attention. Federal...
Iowa Board of Pharmacy Approves NCDQS QAS Accreditation as Part of Waiver to VAWD Requirement Background In 2018, legislation was passed in Iowa that required a company to have VAWD Accreditation as a prerequisite to being awarded wholesale drug distribution...
Puerto Rico’s Regulation of the Drug Supply Chain: Past, Present and Future Overview of Requirements Puerto Rico became a U.S. territory over 100 years ago after the conclusion of the Spanish-American War. As a territory that is still citing laws passed as early as...
Market Viability of Canadian Importation Background Drug Importation has been a longtime coming. The law that developed a framework for importation of prescription drugs originally became effective in January 2012 but over 7 years later, not much has been done. In...
